Skip to content
GLP-1 Decoder

Mounjaro Headache: How Common, How Long It Lasts, What Helps

Headache does not appear on the Mounjaro label as a side effect. What people mean by it: pain in the head.

In the label
Not listed
Most common in the label
Nausea 18%

Mounjaro: a quick overview

How long it remains in the body
100%50%25%0%05 d10 d15 d20 d25 d50%25%12.5%time after the dose

About 5 days for the half-life: after 5 d, half is gone, while five half-lives (25 d) leave about 3%.

Weight lost in its main trial
Mounjaro (SURPASS-1)7.8 kgPlacebo1 kg

SURPASS-1, 40 weeks, type 2 diabetes: participants lost 7.8 kg, compared with 1 kg on placebo.

Price over time
2026$1,112.16$0List priceSelf-pay

Monthly price points in US dollars show the list price and self-pay offers, all read from the maker's price page.

Sources: FDA label (DailyMed), healthsystemtracker.org, pricinginfo.lilly.com.

What the Mounjaro label lists instead

Headache does not appear on the Mounjaro label. The five side effects listed most often are these.

Table 1: Adverse Reactions from the Pool of Placebo-Controlled Trials Reported in ≥5% of MOUNJARO-treated Adult Patients with Type 2 Diabetes Mellitus
Side effectPlaceboMounjaro 5 mgMounjaro 10 mgMounjaro 15 mgMore than placebo, 15 mg
Nausea4%12%15%18%+14 points
Diarrhea9%12%13%17%+8 points
Decreased Appetite1%5%10%11%+10 points
Vomiting2%5%5%9%+7 points
Dyspepsia3%8%8%5%+2 points

Source: Mounjaro label (DailyMed).

Comparing Headache on Mounjaro with other GLP-1s

The label for each drug covers its own trials, and those studies used different groups of people. Use the information as a rough guide.

The pill form shown in the table is Foundayo.

Headache across GLP-1 labels
MedicineHighest rate in the labelDose groupPlaceboPeople in the trials
Wegovy14%2.4 mg10%Adults with obesity or overweight (weight management)
Saxenda13.6%all doses12.6%Adults with obesity or overweight (weight management)
Victoza11%1.2 mg7%Adults with type 2 diabetes
Foundayo9%9 mg7%Adults with obesity or overweight (weight management)
Byetta9%all doses6%Adults with type 2 diabetes
OzempicNot listed–––
RybelsusNot listed–––
MounjaroNot listed–––
ZepboundNot listed–––
TrulicityNot listed–––

Sources: Wegovy label (DailyMed), Foundayo label (DailyMed), Saxenda label (DailyMed), Victoza label (DailyMed), Byetta label (DailyMed).

Source: FDA label (DailyMed).